Silvia Pancani

@dongnocchi.it

68

Scopus Publications

Scopus Publications

  • Adaptation of the Italian Version of the Mealtime Assessment Scale in Pediatric Population (MAS-p)
    Laura Antonucci, Paola Carrozza, Maria Pia Taglioli, Francesca Alberti, Silvia Pancani, Sara Della Bella, Claudio Macchi, Giovanna Cristella
    Dysphagia, 2026
    Unlike what is observed in the adult population, in paediatric rehabilitation, no reliable and validated observational tools are available in the Italian language to evaluate subjects considered to be at risk for swallowing disorders, regardless of the pathology. The aim of this study was to adapt the Mealtime Assessment Scale (MAS) to a paediatric population. Additionally, internal consistency, intra-rater and inter-rater agreement, concurrent validity and discriminative ability were investigated to assess validity and reliability of the scale. The first part of the study consisted in an adaptation of the original version of the MAS to the paediatric population (MAS-p) by a multidisciplinary team. A pilot study, involving 40 subjects, was conducted to assess psychometric properties as validity and reliability in terms of internal consistency, intra- and inter-rater reliability, and discrimination index. Retaining MAS original structure and scoring system, items were maintained, modified, or removed through a revision by the multidisciplinary team to guarantee a correct evaluation in children. None of the patients were lost or had withdrawn. MAS-p showed good internal consistency, both in safety (Cronbach's alpha 0.857) and efficacy scale (Cronbach's alpha 0.885). No improvement was noticed removing items one at a time and an optimal item to total correlation was observed (Cronbach's alpha ≥ 0.80). No items were found to be not assessable. Intra-rater and inter-rater agreement were good for all items (ICC > 0.8 for intra-rater agreement and AD index < 0.66 for inter-rater agreement). A second revision of the scale was carried out by the multidisciplinary team after the pilot study to further modify items to fully adapt to the paediatric population. MAS-p was developed to introduce an objective dysphagia assessment in paediatric rehabilitation. It showed good validity and reliability. The validation process should be completed through further studies.
  • Study protocol of a prospective observational study on the impact of specialized nutritional care on the 3-month outcomes of patients at high risk of malnutrition admitted to a rehabilitation hospital
    Chiara Francesca Gheri, Lucio Lucchin, Alessandra Consales, Barbara Biffi, Silvia Pancani, Giacomo Di Filippo, Sara Madiai, Miriam Cavaleri, Rebecca Celoni, Francesca Campani, Sofia Vidali, Benedetta Giusti, Claudio Macchi, Maria Luisa Eliana Luisi
    Mediterranean Journal of Nutrition and Metabolism, 2026
    Aim Malnutrition is an often underestimated, worldwide, frequent problem with a high prevalence among inpatients, especially the elderly ones. Undernourished patients have an increased risk of comorbidities, complications and a decreased quality of life. Malnutrition is associated with longer hospital stay, increased care needs and costs for the National Health Service (NHS). We describe the protocol of a study conducted to evaluate the impact of specialized nutritional care on 3-month outcomes of patients at high risk of malnutrition at admission and to describe the actual nutritional practice in a rehabilitation setting. Methods In this single-center, prospective, observational study patients at high risk of malnutrition who received standard nutritional care (Group 1) were compared with patients at high risk of malnutrition who received a specialized nutritional care (Group 2). Three months after discharge (follow-up), patients of both groups were interviewed by telephone to collect data regarding number of hospital readmission, emergency department admission, general practitioner (GP) and outpatient visits, diagnostic tests, daily medication use and survival. Conclusion Our study could help to support clinical choices for personalized nutritional interventions to improve rehabilitation outcomes and to decrease the costs for the NHS. This protocol is registered at ClinicalTrials.gov (NCT07183098) under the title “A Prospective Observational Study on the Prevalence of Malnutrition and Clinical-Economic Aspects of the Impact of Specialized Nutritional care on the 3-month Outcomes of Patients at high Risk of malnutrition Admitted to a Rehabilitation Hospital”.
  • REhabilitation of Dysphagia with ACupuncture and auricular Therapy after severe acquired brain injury (REDACT study): a double-blind randomized controlled trial protocol
    Martina Calamini, Agnese De Nisco, Francesca Draghi, Francesca Cecchi, Paola Graziani, Antonello Grippo, Claudio Macchi, Daniela Maccanti, Annamaria Romoli, Silvia Pancani, Carmelo Guido, Bahia Hakiki
    Frontiers in Neurology, 2026
    Neurogenic dysphagia affects up to 99% of patients with severe acquired brain injury (sABI) upon admission to intensive rehabilitation units (IRU) and increase clinical complications, resource use, and mortality. Conventional dysphagia rehabilitation often relies on active techniques, which are hardly applicable in non-collaborative patients, as is often the case with patients after sABI. In the absence of guidelines for dysphagia rehabilitation that consider the heterogeneity and clinical complexity of these patients, acupuncture and auriculotherapy (AA) could represent a valid intervention to be introduced into clinical practice. The aim of this multicenter double-blind, randomized, controlled trial is to evaluate the superiority of AA combined with conventional rehabilitation compared to conventional rehabilitation alone in improving dysphagia in non-cooperative vascular sABI patients. To this end, improvement in swallowing will be measured using both a clinical scale (Mann Assessment of Swallowing Ability-MASA) and a fiber optic endoscopic assessment (Pooling Score). Certain characteristics of patients admitted to IRUs after sABI, such as the rate and timing of decannulation, the infection rate, and the functional outcome measured by the Glasgow Outcome Scale–Extended, will also be taken into consideration as secondary outcomes. By incorporating AA therapy into a personalized rehabilitation program, this study will examine its potential clinical benefits on dysphagia and the feasibility of this approach in the setting of early intensive rehabilitation for patients with sABI. AA could represent a low-cost, accessible bedside treatment complementary to standard rehabilitation, with no adverse effects, applicable in different clinical settings and at all stages of rehabilitation. Clinical trial registration https://clinicaltrials.gov/ct2/show/NCT06888219 , NCT06888219.
  • A comparison of current methods to measure antibodies in type 1 diabetes
    Maria Infantino, Mariangela Manfredi, Emirena Garrafa, Silvia Pancani, Anastasia Lechiara, Emanuela Maria Mobilia, Valentina Grossi, Barbara Lari, Nicola Bizzaro, Giampaola Pesce
    Clinical Chemistry and Laboratory Medicine, 2025
    Objectives Type 1 diabetes (T1D) is a chronic autoimmune disease causing β-cell destruction, hyperglycemia, and lifelong insulin dependence that can lead to severe complications like ketoacidosis, with a 1 % mortality rate in newly diagnosed patients. A significant breakthrough in T1D research was the identification of a long presymptomatic phase, characterized by disease-specific autoantibodies despite the absence of clinical symptoms. The aim of our study was to compare the results of different commercial assays for detecting anti-GAD, -IA-2, -ZnT8 antibodies and IAA to evaluate the state of the art of the current methods in a routine clinical laboratory setting. Methods We have analyzed 87 consecutive samples from patients screened for T1D and evaluated the agreement among four commercial assays (two chemiluminescence immunoassays and two immunoenzymatic assays) for detecting anti-GAD, -IA-2, -ZnT8 antibodies and IAA. Results The agreement among methods for all disease-specific antibodies measured by Cohen’s kappa ranged from 0.514 to 1.000. The highest agreement was found for anti-GAD antibodies (0.923–0.963) and the lowest agreement for IAA (0.514–0.550). The average agreement was 0.796 (SD: 0.170) and it was statistically significant at p&lt;0.001 for all comparisons. Conclusions Even though some differences exist among methods, our findings provide valuable insights into the use of new technologies for T1D diagnosis, demonstrating an overall consistent agreement among assays tested for all antibodies but IAA.
  • It's Never Too Early, It's Never Too Late: The Potential of Health Behaviors for Cardiovascular Health in Nonagenarians. Data From the Mugello Study
    Silvia Pancani, Gemma Lombardi, Francesco Sofi, Guido Pasquini, Federica Vannetti, Francesca Cecchi, Claudio Macchi
    Journals of Gerontology Series A Biological Sciences and Medical Sciences, 2025
    Background The Life’s Essential 8 (LE8) is a composite metric including 4 health behaviors (diet, physical activity, nicotine exposure, and sleep) and 4 health factors (body mass index, nonhigh-density lipoprotein cholesterol, blood glucose, and blood pressure). This study aimed to describe the cardiovascular health (CVH) metrics promoted by LE8 in nonagenarians and to investigate their relationship with mortality at 5 and 10 years. Methods This study was conducted within the framework of the Mugello Study, a longitudinal survey on nonagenarians living in the Mugello area (Tuscany, Italy). One-hundred and fifty-seven subjects (42 males and 115 females, median age 92 years) were administered a series of validated questionnaires and underwent instrumental examinations and blood withdrawal. CVH metrics were calculated according to LE8 guidelines. Physical activity and sleep duration were quantitatively estimated using a monitor device. Results In the male group, after 5 and 10 years of follow-up, a higher Health Behavior score was associated with a lower risk of all-cause mortality (HR: 0.963, p = .005 and HR: 0.972, p = .020; after 5 and 10 years). Differently, in the female group, no significant association was observed between the LE8 total score and subscores and different risk of mortality after 5 and 10 years from the interview. Conclusions These findings highlight the importance of potentially modifiable behaviors in improving survival. They support resource investments to address the needs of individuals in this stage of life and encourage them to be empowered and actively engage in health-promoting behaviors.
  • Harmonization of anti-nuclear antibody testing (ANA) by indirect immunofluorescence assay: Results from ten years of UK NEQAS external quality assessment
    Maria Infantino, Teresa Carbone, Dina Patel, Ravishankar Sargur, Carol Stanley, Amina Bhayat-Cammack, Emirena Garrafa, Silvia Pancani, Mariangela Manfredi, Luis E.C. Andrade, Nicola Bizzaro
    Clinica Chimica Acta, 2025
  • Lesion Conspicuity in Contrast-Enhanced Mammography: A Retrospective Analysis of Tumor Characteristics
    Chiara Bellini, Tommaso Susini, Kassandra Toncelli, Martina Pandolfi, Giuliano Migliaro, Francesca Pugliese, Bianca Vanzi, Ludovica Incardona, Giulia Bicchierai, Federica di Naro, Diego de Benedetto, Sofia Vidali, Silvia Pancani, Vittorio Miele, Jacopo Nori Cucchiari
    Cancers, 2025
    Background/Objectives: The aim of this study is to evaluate the impact of tumor characteristics on lesion conspicuity in contrast-enhanced mammography (CEM) and identify factors associated with different levels of conspicuity. Methods: In this retrospective study, we analyzed 552 patients with breast cancer who underwent CEM. Lesion conspicuity was categorized into three levels: 1 (low), 2 (moderate), and 3 (high). Tumor characteristics included age, histological subtype, hormone receptor status, HER2 status, Ki67 index, tumor grade, and molecular subtype. Univariate and multivariate analyses were conducted to assess associations between lesion conspicuity and these factors. Results: Of the 552 cases, the majority showed mass enhancement (78.1%), followed by non-mass enhancement (NME) (16.8%), and a combination of mass and NME (4.0%). Lesion conspicuity was significantly associated with enhancement type on CEM (p &lt; 0.001). High conspicuity (score 3) was predominantly observed in masses (84.8%) compared to NME (7.6%). Larger tumor dimensions (median 20 mm) were also associated with higher conspicuity (p &lt; 0.001). Molecular subtypes differed significantly in conspicuity, with Luminal A tumors showing lower conspicuity compared to HER2-positive and triple-negative breast cancers (p = 0.025). In multivariate analysis, lesion conspicuity was strongly associated with enhancement type (p &lt; 0.001) and tumor dimensions (p &lt; 0.001), while histological subtype and molecular characteristics had no significant independent impact. Conclusions: Lesion conspicuity in CEM is primarily influenced by the type of enhancement and tumor size. Mass-forming lesions, particularly larger ones, are more conspicuous, while NME tends to result in lower conspicuity. These findings suggest that enhancement patterns and tumor dimensions are key factors to consider when interpreting CEM in breast cancer diagnosis.
  • Cross-cultural adaptation and multicentric validation of the Italian version of the Simplified Evaluation of CONsciousness Disorders (SECONDs)
    Bahia Hakiki, Silvia Pancani, Agnese De Nisco, Anna Maria Romoli, Francesca Draghi, Daniela Maccanti, Anna Estraneo, Alfonso Magliacano, Marcella Spinola, Cinzia Fasano, Matilde Leonardi, Martina Cacciatore, Francesca Giulia Magnani, Davide Sattin, Camilla Ippoliti, Filippo Barbadoro, Antonello Grippo, Claudio Macchi, Charlotte Martial, Olivia Gosseries, Francesca Cecchi
    Plos One, 2025
    Introduction The Coma Recovery Scale-Revised (CRS-R) is the recommended tool to assess consciousness in patients with prolonged Disorders of Consciousness (pDoC). However, the time needed to administer it may limit its use. A shorter tool has been validated: the Simplified Evaluation of CONsciousness Disorders (SECONDs). This multicentre study aimed to develop and validate a cross-cultural adaptation of the SECONDs into Italian. Methods An interdisciplinary expert team, from both Fondazione Don Carlo Gnocchi and Istituto Neurologico Carlo Besta, led the translation processes. Independent certified translators were also involved in a blinded modality. Patients diagnosed with Unresponsive Wakefulness Syndrome (UWS) or Minimally Conscious State (MCS) admitted to 3 Italian rehabilitation units were enrolled. The CRS-R and SECONDs were administered in 5 sessions over two weeks by 3 blinded examiners at each center (3 times, with 2 sessions conducted by the same examiner). Weighted Fleiss’ kappa and Spearman correlation coefficients were used to assess intrarater and interrater reliability and concurrent validity. Results Sixty adults with pDoC were assessed: 23 women; median age: 64 years; 14 trauma, median post-onset time: 2 months. Intrarater and interrater reliability showed almost perfect agreement (kappa coefficients 0.968 and 0.935, respectively; p&lt;0.001). The comparison of CRS-R vs. SECONDs on the same day or the best out of 5 SECONDs/CRS-R led to a substantial to almost perfect agreement both for the total score of the CRS-R and the SECONDs’ Additional Index (ρ = 0.772–1.000; p&lt;0.001) and for the consciousness diagnosis (k = 0.784–0.935; p&lt;0.001). The disagreement rate between the overall best diagnosis of the SECONDs and the best CRS-R diagnosis was 6.7%. Conclusion The Italian version of the SECONDs has been cross-culturally adapted to serve as a shorter assessment tool for the diagnosis of pDoC. Our study shows its excellent reliability and concurrent validity when compared to the CRS-R.
  • A new microdot array-based immunoassay for the diagnosis of systemic autoimmune diseases
    Maria INFANTINO, Francesca PAVIA, Valentina GROSSI, Barbara LARI, Maurizio BENUCCI, Francesca LI GOBBI, Silvia PANCANI, Mariangela MANFREDI
    Rivista Italiana Della Medicina Di Laboratorio, 2024
    BACKGROUND: The early reliable detection and quantification of autoantibodies play an important role in autoimmune diseases diagnosis and in disease course monitoring. New technologies such as multiplexed determination of autoantibodies have been recently introduced and are increasingly performed. The aim of this study was to evaluate the ability of a new microdot array-based multiparametric assay (ZENIT AMiDot CTD Panel, A. Menarini Diagnostics) to correctly classify patients with autoimmune rheumatic diseases (ARDs) and normal blood donor sera, and compare with fluorescence enzyme immunoassay (FEIA) for the detection of anti-extractable nuclear antigens (ENA).METHODS: The study included 69 consecutive samples from patients with ARDs that were analyzed with two different methods (FEIA and AMiDot) for the detection of anti-CENP B and of six anti-ENA antibodies: anti-Scl70, anti-SSB/La, anti-Jo1, anti-U1RNP, anti-Ro52 and anti-Ro60. Sixty-eight blood donors were used as control group. Tests were run on automated slide processor ZENIT FLOW, then slides were imaged and analysed using ZENIT fast.RESULTS: Since the samples were selected for at least one antibody positivity with a ARD diagnosis, we did not calculate clinical sensitivity but only specificity, which was 98.53%, ranging from 90% for anti-SSB/La antibodies to 100% for anti-CENP-B. Mean agreement among methods assessed by Cohen’s kappa was 0.816±0.240.CONCLUSIONS: The assay showed a good clinical performance and may be considered a valuable aid in detecting ARDs patients, offering an alternative to the methods largely in use today, such as FEIA.
  • Role of Blood P-Tau Isoforms (181, 217, 231) in Predicting Conversion from MCI to Dementia Due to Alzheimer’s Disease: A Review and Meta-Analysis
    Gemma Lombardi, Silvia Pancani, Riccardo Manca, Micaela Mitolo, Simone Baiardi, Federico Massa, Luigi Coppola, Monica Franzese, Emanuele Nicolai, Franca Rosa Guerini, Roberta Mancuso, Cristina Agliardi, Simone Agostini, Matteo Pardini, Gianni Virgili, Sandro Sorbi, Piero Parchi, Benedetta Nacmias, Annalena Venneri
    International Journal of Molecular Sciences, 2024
    Blood-based biomarkers are minimally invasive tools to detect the pathological changes of Alzheimer’s Disease (AD). This meta-analysis aims to investigate the use of blood-derived p-tau isoforms (181, 217, 231) to predict conversion from mild cognitive impairment (MCI) to AD dementia (ADD). Studies involving MCI patients with data on blood p-tau isoforms at baseline and clinical diagnosis at follow-up (≥1 year) were included. Twelve studies on p-tau 181 (4340 MCI, conversion rate 20.6%), four on p-tau 217 (913 MCI, conversion rate 33.4%), and one on p-tau 231 (135 MCI, conversion rate 33%) were included. For p-tau 181, the pooled area under the receiver operating characteristic curve (AUC) was 0.73 (95% CI = 0.68–0.78), and for p-tau 217 was 0.85 (95% CI = 0.75–0.91). Plasma levels of p-tau 181 had good discriminatory power to identify MCI patients who will convert to ADD. Although only four studies on p-tau 217 have been included in the meta-analysis, in the last year the predictive power of p-tau 217 is emerging as superior to that of other isoforms. However, given the high heterogeneity detected in the p-tau 217 studies included in this meta-analysis, additional supportive evidence is needed. Insufficient results were available for p-tau 231. These findings support the prognostic utility of p-tau 181 and p-tau 217 measured in blood to predict progression to ADD in MCI and encourage its future implementation in clinical practice.
  • Early predictors of long-term participation in patients with severe acquired traumatic injury discharged from Intensive Rehabilitation Unit
    Bahia HAKIKI, Silvia PANCANI, Francesca DRAGHI, Anna M. ROMOLI, Daniela MACCANTI, Agnese DE NISCO, Claudio MACCHI, Francesca CECCHI
    European Journal of Physical and Rehabilitation Medicine, 2024
  • Implications of the Consciousness State on Decannulation in Patients With a Prolonged Disorder of Consciousness
    Francesca Draghi, Silvia Pancani, Agnese De Nisco, Anna Maria Romoli, Daniela Maccanti, Rachele Burali, Antonello Grippo, Claudio Macchi, Francesca Cecchi, Bahia Hakiki
    Archives of Physical Medicine and Rehabilitation, 2024
  • Evaluation of a New Multiparametric Microdot Array-Based Immunoassay Panel for Systemic Autoimmune Disease Diagnosis
    Maria Infantino, Francesca Pavia, Valentina Grossi, Barbara Lari, Maurizio Benucci, Francesca Li Gobbi, Silvia Pancani, Mariangela Manfredi
    Journal of Personalized Medicine, 2024
  • Depressive Symptoms Moderate the Association Between Functional Level at Admission to Intensive Post-Stroke Rehabilitation and Effectiveness of the Intervention
    Salvatore Mazzeo, Silvia Pancani, Alessandro Sodero, Chiara Castagnoli, Angela Maria Politi, Monica Barnabè, Francesca Ciullini, Marco Baccini, Antonello Grippo, Bahia Hakiki, Claudio Macchi, Francesca Cecchi
    Journal of Geriatric Psychiatry and Neurology, 2024
  • Understanding the interplay between APO E polymorphism and cognition in the Italian oldest old: results from the “Mugello study”
    Gemma Lombardi, Silvia Pancani, Silvia Bagnoli, Federica Vannetti, Benedetta Nacmias, Sandro Sorbi, Francesca Cecchi, Claudio Macchi
    Neurological Sciences, 2024
  • Impact of age on the predictive value of NT-proBNP in patients with diabetes mellitus stabilised after an acute coronary syndrome
    Stefano Savonitto, Nuccia Morici, Silvia Pancani, Anna Nozza, Francesco Cosentino, Pasquale Perrone Filardi, Claudio Cavallini, Fabio Angeli, Barbara E. Stähli, Hiddo J.L. Heerspink, Andrea Mannini, Gregory G. Schwartz, A. Michael Lincoff, Jean-Claude Tardif, Diederick E. Grobbee
    Diabetes Research and Clinical Practice, 2024
  • Predicting the functional outcome of intensive inpatient rehabilitation after stroke: results from the RIPS Study
    Alessandro SODERO, Silvia CAMPAGNINI, Anita PAPERINI, Chiara CASTAGNOLI, Ines HOCHLEITNER, Angela M. POLITI, Donata BARDI, Benedetta BASAGNI, Teresa BARRETTA, Erika GUOLO, Caterina TRAMONTI, Silvia PANCANI, Bahia HAKIKI, Antonello GRIPPO, Andrea MANNINI, Benedetta NACMIAS, Marco BACCINI, Claudio MACCHI, Francesca CECCHI
    European Journal of Physical and Rehabilitation Medicine, 2024
  • Trunk Control Test as a Main Predictor of the Modified Barthel Index Score at Discharge From Intensive Post-acute Stroke Rehabilitation: Results From a Multicenter Italian Study
    Leonardo Pellicciari, Benedetta Basagni, Anita Paperini, Silvia Campagnini, Alessandro Sodero, Bahia Hakiki, Chiara Castagnoli, Angela Maria Politi, Lucia Avila, Manuele Barilli, Emanuela Romano, Silvia Pancani, Andrea Mannini, Federico Sensoli, Emilia Salvadori, Anna Poggesi, Antonello Grippo, Claudio Macchi, Marco Baccini, Maria Chiara Carrozza, Francesca Cecchi
    Archives of Physical Medicine and Rehabilitation, 2024
  • MoCA Domain-Specific Pattern of Cognitive Impairment in Stroke Patients Attending Intensive Inpatient Rehabilitation: A Prospective Study
    Benedetta Basagni, Serena Malloggi, Cristina Polito, Leonardo Pellicciari, Silvia Campagnini, Silvia Pancani, Andrea Mannini, Paola Gemignani, Emilia Salvadori, Sara Marignani, Fabio Giovannelli, Maria Pia Viggiano, Bahia Hakiki, Antonello Grippo, Claudio Macchi, Francesca Cecchi
    Behavioral Sciences, 2024
  • Comparing the effects of augmented virtual reality treadmill training versus conventional treadmill training in patients with stage II-III Parkinson’s disease: the VIRTREAD-PD randomized controlled trial protocol
    Gemma Lombardi, Marco Baccini, Alice Gualerzi, Silvia Pancani, Silvia Campagnini, Stefano Doronzio, Diego Longo, Alessandro Maselli, Giulio Cherubini, Michele Piazzini, Tommaso Ciapetti, Cristina Polito, Samuele Pinna, Chiara De Santis, Marzia Bedoni, Claudio Macchi, Silvia Ramat, Francesca Cecchi
    Frontiers in Neurology, 2024
  • Testing for isotypes does not help differentiating rheumatoid arthritis from other rheumatoid factor positive diseases
    Maria Infantino, Boaz Palterer, Maurizio Benucci, Valentina Grossi, Silvia Pancani, Mariangela Manfredi, Nicola Bizzaro
    Immunologic Research, 2023
  • Lack of comparability of immunoassays for rheumatoid factor isotypes
    Maria Infantino, Boaz Palterer, Silvia Pancani, Maurizio Benucci, Valentina Grossi, Mariangela Manfredi, Nicola Bizzaro
    Clinical Chemistry and Laboratory Medicine, 2023
  • Relationship between Nutritional Risk, Clinical and Demographic Characteristics, and Pressure Ulcers in Patients with Severe Acquired Brain Injuries Attending a Rehabilitative Program
    Chiara Francesca Gheri, Luca Scalfi, Barbara Biffi, Silvia Pancani, Sara Madiai, Olivia Di Vincenzo, Michele Ghaderi, Rebecca Celoni, Mara Dalladonna, Francesca Draghi, Daniela Maccanti, Claudio Macchi, Anna Maria Romoli, Francesca Cecchi, Bahia Hakiki, Maria Luisa Eliana Luisi
    Nutrients, 2023
  • Sleep profile in a population of community-dwelling nonagenarians: data from the Mugello study
    Barbara Binazzi, Federica Provini, Silvia Pancani, Antonello Grippo, Federica Vannetti, Guido Pasquini, Roberta Frandi, Nona Turcan, Lorenzo Razzolini, Francesca Cecchi, Raffaello Molino Lova, Claudio Macchi
    Psychogeriatrics, 2023
  • Correlates of participation six months after stroke in an Italian population: results from the RIPS(Post-Stroke Intensive Rehabilitation) Study
    Chiara CASTAGNOLI, Silvia PANCANI, Teresa BARRETTA, Leonardo PELLICCIARI, Silvia CAMPAGNINI, Benedetta BASAGNI, Camilla GUCCI, Alessandro SODERO, Erika GUOLO, Bahia HAKIKI, Antonello GRIPPO, Andrea MANNINI, Claudio MACCHI, Francesca CECCHI
    European Journal of Physical and Rehabilitation Medicine, 2023
  • Cognitive Profile in Patients Admitted to Intensive Rehabilitation after Stroke Is Associated with the Recovery of Dysphagia: Preliminary Results from the RIPS (Intensive Post-Stroke Rehabilitation) Study
    Benedetta Basagni, Sara Marignani, Silvia Pancani, Andrea Mannini, Bahia Hakiki, Antonello Grippo, Claudio Macchi, Francesca Cecchi
    Seminars in Speech and Language, 2023
  • Cognitive reserve index and long-term disability in patients with severe traumatic brain injury discharged from the intensive rehabilitation unit
    Bahia Hakiki, Silvia Pancani, Anna Maria Romoli, Francesca Draghi, Daniela Maccanti, Andrea Mannini, Francesca Cecchi
    Frontiers in Neurology, 2023
  • Italian translation and transcultural validation of an assessment tool for community ambulation in stroke survivors: the modified Functional Walking Categories (mFWC)
    Carmen Barbato, Laura Antonucci, Leonardo Pellicciari, Chiara Castagnoli, Ines Hochleitner, Anita Paperini, Silvia Pancani, Sonia Verdesca, Benedetta Basagni, Claudio Macchi, Francesca Cecchi
    Physiotherapy Theory and Practice, 2023
  • Intra- and inter-rater reliability of the Italian Fugl-Meyer assessment of upper and lower extremity
    Ines Hochleitner, Leonardo Pellicciari, Chiara Castagnoli, Anita Paperini, Angela Maria Politi, Silvia Campagnini, Silvia Pancani, Benedetta Basagni, Filippo Gerli, Maria Chiara Carrozza, Claudio Macchi, Margit Alt Murphy, Francesca Cecchi
    Disability and Rehabilitation, 2023
  • 12-month survival in nonagenarians inside the Mugello study: on the way to live a century
    Silvia Pancani, Gemma Lombardi, Francesco Sofi, Anna Maria Gori, Roberta Boni, Chiara Castagnoli, Anita Paperini, Guido Pasquini, Federica Vannetti, Raffaello Molino Lova, Claudio Macchi, Francesca Cecchi
    BMC Geriatrics, 2022
  • Extra-Linguistic Cognitive Functions Involved in the Token Test: Results from a Cohort of Non-Aphasic Stroke Patients with Right Hemisphere Lesion
    Benedetta Basagni, Silvia Pancani, Leonardo Pellicciari, Paola Gemignani, Emilia Salvadori, Sara Marignani, Antonello Grippo, Bahia Hakiki, Andrea Mannini, Donata Bardi, Ilaria Pellegrini, Maria Pia Viggiano, Fabio Giovannelli, Claudio Macchi, Francesca Cecchi
    Behavioral Sciences, 2022
  • Predictors of Mortality in 433 Nonagenarians Inside the Mugello Study: A 10 Years Follow-Up Study
    Silvia Pancani, Gemma Lombardi, Francesco Sofi, Anna Maria Gori, Roberta Boni, Chiara Castagnoli, Anita Paperini, Guido Pasquini, Federica Vannetti, Raffaello Molino Lova, Claudio Macchi, Francesca Cecchi
    Journal of Aging and Health, 2022
  • Current technologies for anti-ENA antibody detection: State-of-the-art of diagnostic immunoassays
    Maria Infantino, Teresa Carbone, Ignazio Brusca, Maria-Grazia Alessio, Giulia Previtali, Stefan Platzgummer, Giusi Paura, Caterina Castiglione, Martina Fabris, Giampaola Pesce, Brunetta Porcelli, Lucia Terzuoli, Maria-Romana Bacarelli, Marilina Tampoia, Luigi Cinquanta, Danilo Villalta, Francesca Buzzolini, Boaz Palterer, Silvia Pancani, Maurizio Benucci, Mariangela Manfredi, Nicola Bizzaro
    Journal of Immunological Methods, 2022
  • Assessing Relationships between Physically Demanding Work and Late-Life Disability in Italian Nonagenarian Women Living in a Rural Area
    Gemma Lombardi, Silvia Pancani, Francesca Lorenzini, Federica Vannetti, Guido Pasquini, Roberta Frandi, Nona Turcan, Lorenzo Razzolini, Raffaello Molino Lova, Francesca Cecchi, Claudio Macchi
    International Journal of Environmental Research and Public Health, 2022
  • Italian translation and cross-cultural validation of an assessment tool for participation in stroke survivors: the Frenchay Activities Index
    Laura Antonucci, Carmen Barbato, Leonardo Pellicciari, Anita Paperini, Ines Hochleitner, Chiara Castagnoli, Sonia Verdesca, Giulia Lucidi, Sara Marignani, Silvia Pancani, Benedetta Basagni, Claudio Macchi, Francesca Cecchi
    Neurological Sciences, 2022
  • Lipid and metabolite correlation networks specific to clinical and biochemical covariate show differences associated with sexual dimorphism in a cohort of nonagenarians
    Francesca Di Cesare, Leonardo Tenori, Gaia Meoni, Anna Maria Gori, Rossella Marcucci, Betti Giusti, Raffaele Molino-Lova, Claudio Macchi, Silvia Pancani, Claudio Luchinat, Edoardo Saccenti
    Geroscience, 2022
  • Critical Illness Polyneuropathy and Myopathy and Clinical Detection of the Recovery of Consciousness in Severe Acquired Brain Injury Patients with Disorders of Consciousness after Rehabilitation
    Bahia Hakiki, Francesca Cecchi, Silvia Pancani, Anna Maria Romoli, Francesca Draghi, Maenia Scarpino, Raisa Sterpu, Andrea Mannini, Claudio Macchi, Antonello Grippo
    Diagnostics, 2022
  • Decannulation and improvement of responsiveness in patients with disorders of consciousness
    Bahia Hakiki, Silvia Pancani, Francesca Draghi, Emilio Portaccio, Ariela Tofani, Barbara Binazzi, Romoli Anna Maria, Maenia Scarpino, Claudio Macchi, Francesca Cecchi
    Neuropsychological Rehabilitation, 2022
  • Impact of decompressive craniectomy on functional outcome of severe acquired brain injuries patients, at discharge from intensive inpatient rehabilitation
    Bahia Hakiki, Piergiuseppe Liuzzi, Gastone Pansini, Silvia Pancani, Annamaria Romoli, Francesca Draghi, Simone Orlandini, Andrea Mannini, Alessandro Della Puppa, Claudio Macchi, Francesca Cecchi
    Disability and Rehabilitation, 2022
  • Validation and accuracy evaluation of automatic segmentation for knee joint pre-planning
    Edoardo Bori, Silvia Pancani, Salvatore Vigliotta, Bernardo Innocenti
    Knee, 2021
  • The WHO International Standard for COVID-19 serological tests: towards harmonization of anti-spike assays
    Maria Infantino, Massimo Pieri, Marzia Nuccetelli, Valentina Grossi, Barbara Lari, Flaminia Tomassetti, Graziella Calugi, Silvia Pancani, Maurizio Benucci, Patrizia Casprini, Mariangela Manfredi, Sergio Bernardini
    International Immunopharmacology, 2021
  • Prevention and control of COVID-19 in the penitentiary of Florence
    Mirco Capacci, Maria Infantino, Valentina Grossi, Barbara Lari, Sergio Fabbri, Alessio Bellucci, Patrizia Sani, Alessandro Perri, Maurizio Benucci, Lorenza Cristiano, Silvia Pancani, Luciana Amendola, Francesca Veneziani, Patrizia Casprini, Sandra Rogialli, Mariangela Manfredi
    Clinical Chemistry and Laboratory Medicine, 2021
  • Predictors of Function, Activity, and Participation of Stroke Patients Undergoing Intensive Rehabilitation: A Multicenter Prospective Observational Study Protocol
    Bahia Hakiki, Anita Paperini, Chiara Castagnoli, Ines Hochleitner, Sonia Verdesca, Antonello Grippo, Maenia Scarpino, Antonio Maiorelli, Irene Eleonora Mosca, Paola Gemignani, Marco Borsotti, Maria Assunta Gabrielli, Emilia Salvadori, Anna Poggesi, Giulia Lucidi, Catiuscia Falsini, Monica Gentilini, Monica Martini, Maria Luisa Eliana Luisi, Barbara Biffi, Paolo Mainardi, Teresa Barretta, Silvia Pancani, Andrea Mannini, Silvia Campagnini, Silvia Bagnoli, Assunta Ingannato, Benedetta Nacmias, Claudio Macchi, Maria Chiara Carrozza, Francesca Cecchi
    Frontiers in Neurology, 2021
  • Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies
    Maria Infantino, Mariangela Manfredi, Valentina Grossi, Barbara Lari, Sergio Fabbri, Maurizio Benucci, Alberto Fortini, Arianna Damiani, Emanuela Maria Mobilia, Marta Panciroli, Silvia Pancani, Giampaola Pesce
    Journal of Medical Virology, 2021
  • Impact of occupational complexity on cognitive decline in the oldest-old
    Bahia Hakiki, Silvia Pancani, Emilio Portaccio, Raffaello Molino-Lova, Francesco Sofi, Claudio Macchi, Francesca Cecchi
    Aging and Mental Health, 2021
  • Transcultural translation and validation of Fugl–Meyer assessment to Italian
    F. Cecchi, C. Carrabba, F. Bertolucci, C. Castagnoli, C. Falsini, B. Gnetti, I. Hochleitner, G. Lucidi, M. Martini, I. E. Mosca, S. Pancani, A. Paperini, S. Verdesca, C. Macchi, M. Alt Murphy
    Disability and Rehabilitation, 2021
  • Development and implementation of a stroke rehabilitation integrated care pathway in an italian no profit institution: An observational study
    Francesca CECCHI, Manuela DIVERIO, Chiara ARIENTI, Elena CORBELLA, Federico MARRAZZO, Gabriele SPERANZA, Elisabetta DEL ZOTTO, Giuliana POGGIANTI, Francesco GIGLIOTTI, Paola POLCARO, Margherita ZINGONI, Desiderio ANTONIOLI, Lucia AVILA, Manuele BARILLI, Emanuela ROMANO, Lucilla LANDUCCI PELLEGRINI, Massimo GAMBINI, Sonia VERDESCA, Federica BERTOLUCCI, Irene MOSCA, Paola GEMIGNANI, Anita PAPERINI, Chiara CASTAGNOLI, Ines HOCHLEITNER, Maria L. LUISI, Giulia LUCIDI, Bahia HAKIKI, Maria A. GABRIELLI, Morena FRUZZETTI, Annalisa BRUZZI, Enrico BACCI BONOTTI, Silvia PANCANI, Silvia GALERI, Claudio MACCHI, Irene APRILE
    European Journal of Physical and Rehabilitation Medicine, 2020
  • Analysis of Feasibility, Adherence, and Appreciation of a Newly Developed Tele-Rehabilitation Program for People With MCI and VCI
    Irene Eleonora Mosca, Emilia Salvadori, Filippo Gerli, Laura Fabbri, Silvia Pancani, Giulia Lucidi, Gemma Lombardi, Leonardo Bocchi, Stefania Pazzi, Francesca Baglio, Federica Vannetti, Sandro Sorbi, Claudio Macchi
    Frontiers in Neurology, 2020
  • Decannulation After a Severe Acquired Brain Injury
    Bahia Hakiki, Francesca Draghi, Silvia Pancani, Emilio Portaccio, Antonello Grippo, Barbara Binazzi, Ariela Tofani, Maenia Scarpino, Claudio Macchi, Francesca Cecchi
    Archives of Physical Medicine and Rehabilitation, 2020
  • Time-course of running treadmill adaptation in novice treadmill runners
    Laura Simoni, Guido Pasquini, Silvia Pancani, Federica Vannetti, Claudio Macchi, Silvia Pogliaghi
    Journal of Sports Sciences, 2020
  • The Visual Scanning Test: a newly developed neuropsychological tool to assess and target rehabilitation of extrapersonal visual unilateral spatial neglect
    Marco Borsotti, , Irene Eleonora Mosca, Francesca Di Lauro, Silvia Pancani, Cristiano Bracali, Tomas Dore, Claudio Macchi, Francesca Cecchi
    Neurological Sciences, 2020
  • Independent Functioning in Nonagenarians Living in a Rural Italian Community: The Mugello Study
    F. Cecchi, S. Pancani, R. Molino-Lova, C. Castagnoli, A. Paperini, R. Boni, G. Gori, C. Macchi, and
    Journal of Applied Gerontology, 2020
  • Relationship between Lower Limb Kinematics and Upper Trunk Acceleration in Recreational Runners
    Laura Simoni, Silvia Pancani, Federica Vannetti, Claudio Macchi, Guido Pasquini
    Journal of Healthcare Engineering, 2020
  • D-dimer as an indicator of prognosis in SARS-CoV-2 infection: A systematic review
    Sofia Vidali, Daniele Morosetti, Elsa Cossu, Maria Luisa Eliana Luisi, Silvia Pancani, Vittorio Semeraro, Guglielmo Consales
    Erj Open Research, 2020
  • Vision Optical-Based Evaluation of Senshand Accuracy for Parkinson's Disease Motor Assessment
    Erika Rovini, Dario Esposito, Laura Fabbri, Silvia Pancani, Federica Vannetti, Filippo Cavallo
    2019 IEEE International Symposium on Measurements and Networking M and N 2019 Proceedings, 2019
  • Association between physical activity and functional and cognitive status in nonagenarians: Results from the Mugello study
    Silvia Pancani, Federica Vannetti, Francesco Sofi, Francesca Cecchi, Guido Pasquini, Laura Fabbri, Irene Eleonora Mosca, Claudio Macchi
    International Psychogeriatrics, 2019
  • HDL Cholesterol Is Independently Associated with Cognitive Function in Males But Not in Females within a Cohort of Nonagenarians: The Mugello Study
    Silvia Pancani, , F. Sofi, F. Cecchi, C. Macchi
    Journal of Nutrition Health and Aging, 2019
  • Preliminary Investigation of a Newly Developed Tele-Rehabilitation Program for People Living with MCI Condition
    L. Martini, L. Fabbri, S. Pancani, I. Mosca, F. Gerli, F. Vannetti
    Biosystems and Biorobotics, 2019
  • The Games for Older Adults Active Life (GOAL) project for people with mild cognitive impairment and vascular cognitive impairment: A study protocol for a randomized controlled trial
    Laura Fabbri, Irene Eleonora Mosca, Filippo Gerli, Leonardo Martini, Silvia Pancani, Giulia Lucidi, Federica Savazzi, Francesca Baglio, Federica Vannetti, Claudio Macchi, The GOAL Working Group
    Frontiers in Neurology, 2019
  • Predictors of recovering ambulation after hip fracture inpatient rehabilitation
    Francesca Cecchi, Silvia Pancani, Desiderio Antonioli, Lucia Avila, Manuele Barilli, Massimo Gambini, Lucilla Landucci Pellegrini, Emanuela Romano, Chiara Sarti, Margherita Zingoni, Maria Assunta Gabrielli, Federica Vannetti, Guido Pasquini, Claudio Macchi
    BMC Geriatrics, 2018
  • Efficacy of the Head Up collar in facilitating functional head movements in patients with Amyotrophic Lateral Sclerosis
    Silvia Pancani, Wendy Tindale, Pamela J. Shaw, Claudia Mazzà, Christopher J. McDermott
    Clinical Biomechanics, 2018
  • Experimental measurement of forces during percutaneous dilatational tracheostomy
    Silvia Pancani, Antonio Virga, Rosario Spina, Adriano Peris, Andrea Corvi
    Proceedings of the Institution of Mechanical Engineers Part H Journal of Engineering in Medicine, 2018
  • Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion
    Giuseppe Lepore, Riccardo Bonfanti, Lutgarda Bozzetto, Vincenzo Di Blasi, Angela Girelli, Giorgio Grassi, Dario Iafusco, Luigi Laviola, Ivana Rabbone, Riccardo Schiaffini, Daniela Bruttomesso, F. Mammì, M. Bruzzese, M. Schettino, M.G. Nuzzo, V. Di Blasi, R. Fresa, C. Lambiase, D. Iafusco, A. Zanfardino, S. Confetto, L. Bozzetto, G. Annuzzi, A. Alderisio, G. Riccardi, S. Gentile, G. Marino, G. Guarino, S. Zucchini, G. Maltoni, T. Suprani, V. Graziani, M. Nizzoli, S. Acquati, R. Cavani, S. Romano, M. Michelini, E. Manicardi, R. Bonadonna, A. Dei Cas, E. Dall'aglio, M. Papi, S. Riboni, V. Manicardi, E. Manicardi, E. Manicardi, V. Pugni, A. Lasagni, M.E. Street, U. Pagliani, C. Rossi, R. Assaloni, B. Brunato, C. Tortul, G. Zanette, P. Li Volsi, M. Zanatta, L. Tonutti, S. Agus, M.A. Pellegrini, P. Ceccano, G. Pozzilli, Beretta Anguissola, R. Buzzetti, C. Moretti C, G. Leto, P. Pozzilli, S. Manfrini, A.R. Maurizi, S. Leotta, M. Altomare, S. Abbruzzese, S. Carletti, C. Suraci, S. Filetti, M.L. Manca Bitti, S. Arcano, M.G. Cavallo, M. De Bernardinis, D. Pitocco, S. Caputo, A. Rizzi, A. Manto, R. Schiaffini, M. Cappa, D. Benevento, S. Frontoni, I. Malandrucco, S. Morano, T. Filardi, D. Lauro, M.A. Marini, E. Castaldo, D. Sabato, F. Tuccinardi, E. Forte, P. Viterbori, C. Arnaldi, N. Minuto, G. d'Annunzio, A. Corsi, R. Rota, C. Scaranna, R. Trevisan, U. Valentini, A. Girelli, S. Bonfadini, E. Zarra, A. Plebani, E. Prandi, B. Felappi, A. Rocca, E. Meneghini, P. Galli, P. Ruggeri, E. Carrai, L. Fugazza, V. Baggi, D. Conti, E. Bosi, A. Laurenzi, A. Caretto, C. Molinari, E. Orsi, V. Grancini, V. Resi, R. Bonfanti, V. Favalli, C. Bonura, A. Rigamonti, M. Bonomo, F. Bertuzzi, B. Pintaudi, O. Disoteo, G. Perseghin, S. Perra, L. Chiovato, P. De Cata, F. Zerbini, E. Lovati, M. Laneri, L. Guerraggio, A.C. Bossi, V. De Mori, M. Galetta, I. Meloncelli, A. Aiello A, S. Di Vincenzo, A. Nuzzi, E. Fraticelli, E. Ansaldi, M. Battezzati, M. Lombardi, M. Balbo, R. Lera, A. Secco, V. De Donno, F. Cadario, S. Savastio, C. Ponzani, G. Aimaretti, I. Rabbone, G. Ignaccolo, D. Tinti, F. Cerutti, F. Bari, F. Giorgino, E. Piccinno, O. Zecchino, M. Cignarelli, O. Lamacchia, G. Picca, S. De Cosmo, A. Rauseo, L. Tomaselli, A. Tumminia, C. Egiziano, A.M. Scarpitta, F. Maggio, F. Cardella, R. Roppolo, V. Provenzano, M. Fleres, A. Scorsone, A. Scatena, G. Gregori, S. Lucchesi, F. Gadducci, S. Di Cianni, S. Pancani, S. Del Prato, M. Aragona, I. Crisci, A. Calianno, B. Fattor, D. Crazzolara, P. Reinstadler, S. Longhi, G. Incelli, S. Rauch, T. Romanelli, M. Orrasch, V. Cauvin, R. Franceschi, C. Lalli, A. Pianta, A. Marangoni, C.N. Aricò, N. Marin, N. Nogara, N. Simioni, A. Filippi, G.L. Gidoni Guarneri, M.L. Contin M.L, A.P. Decata, L. Bondesan, L. Confortin, A. Coracina, S. Lombardi, S. Costa Padova, E. Cipponeri, R. Scotton, S. Galasso, F. Boscari, M.S. Zanon, C. Vinci, G. Lisato, L. Gottardo, E. Bonora, M. Trombetta, C. Negri, C. Brangani, C. Maffeis, A. Sabbion, M. Marigliano
    Nutrition Metabolism and Cardiovascular Diseases, 2018
  • A comfort assessment of existing cervical orthoses
    Joe Langley, Silvia Pancani, Karen Kilner, Heath Reed, Andy Stanton, Nicola Heron, Simon Judge, Avril McCarthy, Susan Baxter, Claudia Mazzà, Christopher J. McDermott
    Ergonomics, 2018
  • Aging process, adherence to Mediterranean diet and nutritional status in a large cohort of nonagenarians: Effects on endothelial progenitor cells
    F. Cesari, F. Sofi, R. Molino Lova, F. Vannetti, G. Pasquini, F. Cecchi, R. Marcucci, A.M. Gori, C. Macchi, R. Boni, C. Castagnoli, R. Frandi, S. Pancani, A. Paperini, E. Portaccio, L. Razzolini, N. Turcan, D. Valecchi, G.F. Gensini, R. Abbate
    Nutrition Metabolism and Cardiovascular Diseases, 2018
  • Hemoglobin concentration is associated with self-reported disability and reduced physical performance in a community dwelling population of nonagenarians: the Mugello Study
    Francesca Cecchi, , Silvia Pancani, Federica Vannetti, Roberta Boni, Chiara Castagnoli, Anita Paperini, Guido Pasquini, Francesco Sofi, Raffaele Molino-Lova, Claudio Macchi
    Internal and Emergency Medicine, 2017
  • An objective functional characterisation of head movement impairment in individuals with neck muscle weakness due to amyotrophic lateral sclerosis
    Silvia Pancani, Wendy Tindale, Pamela J. Shaw, Christopher J. McDermott, Claudia Mazzà
    Plos One, 2017
  • Assessment of the Sheffield Support Snood, an innovative cervical orthosis designed for people affected by neck muscle weakness
    Silvia Pancani, Jennifer Rowson, Wendy Tindale, Nicola Heron, Joe Langley, Avril D. McCarthy, Ann Quinn, Heath Reed, Andrew Stanton, Pamela J. Shaw, Christopher J. McDermott, Claudia Mazzà
    Clinical Biomechanics, 2016